These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8193060)

  • 1. Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity.
    Yao JK; van Kammen DP
    Schizophr Res; 1994 Feb; 11(3):209-16. PubMed ID: 8193060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition.
    Yao JK; van Kammen DP; Welker JA
    Schizophr Res; 1994 Oct; 13(3):217-26. PubMed ID: 7841134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures.
    Yao JK; van Kammen DP; Gurklis J
    Schizophr Res; 1994 Oct; 13(3):227-32. PubMed ID: 7841135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation and dense granule secretion in schizophrenia.
    Yao JK; van Kammen DP; Gurklis J; Peters JL
    Psychiatry Res; 1994 Oct; 54(1):13-24. PubMed ID: 7701025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBC and plasma choline in neuroleptic-treated schizophrenic patients.
    Lawson WB; Jeste DV; Hanin I; Kopp U; Wyatt RJ
    Psychiatry Res; 1989 Jul; 29(1):45-53. PubMed ID: 2570429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
    Khot V; DeVane CL; Korpi ER; Venable D; Bigelow LB; Wyatt RJ; Kirch DG
    J Clin Psychopharmacol; 1993 Apr; 13(2):120-7. PubMed ID: 8463444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
    van Kammen DP; Peters J; van Kammen WB; Nugent A; Goetz KL; Yao J; Linnoila M
    Biol Psychiatry; 1989 Jun; 26(2):176-88. PubMed ID: 2472177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Pycnogenol on the erythrocyte membrane fluidity.
    Sivonová M; Waczulíková I; Kilanczyk E; Hrnciarová M; Bryszewska M; Klajnert B; Duracková Z
    Gen Physiol Biophys; 2004 Mar; 23(1):39-51. PubMed ID: 15270128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia.
    Muller S; Ziegler O; Donner M; Drouin P; Stoltz JF
    Atherosclerosis; 1990 Aug; 83(2-3):231-7. PubMed ID: 2242099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.
    Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M
    Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients.
    van Kammen DP; Kelley ME; Gurklis JA; Gilbertson MW; Yao JK; Condray R; Peters JL
    Neuropsychopharmacology; 1996 Apr; 14(4):275-83. PubMed ID: 8924195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.
    Glen AI; Glen EM; Horrobin DF; Vaddadi KS; Spellman M; Morse-Fisher N; Ellis K; Skinner FS
    Schizophr Res; 1994 Apr; 12(1):53-61. PubMed ID: 8018585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane lipid fluidity and filterability of red blood cells from adults and newborns.
    Crespo LM; Bifano EM; Freedman JC
    Pediatr Res; 1988 Oct; 24(4):433-7. PubMed ID: 3140204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
    Magliozzi JR; Hollister LE; Arnold KV; Earle GM
    Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
    Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M
    Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the physical properties of red cell ghost membranes in the affective disorders and psychoses. A fluorescence polarization study.
    Hitzemann RJ; Hirschowitz J; Garver DL
    J Affect Disord; 1986; 10(3):227-32. PubMed ID: 2943777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.